For decades, scientists puzzled over the protein-folding problem of whether a protein’s structure and shape could be ...

With its first AI-based drug currently undergoing clinical ... “Chemiverse helps to design novel drug candidates using chem-informatics, structure- and ligand-based analysis, and then proposes ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Scientists at The Institute of Cancer Research (ICR) led by Professor Paul Workman, a world leader in the discovery of small-molecule cancer drugs, and Dr Albert Antolin at IDIBELL, who is developing ...

Using AI to accelerate biotech is fast becoming standard practice, and companies offering services to deploy the tech quickly ...

Ramy Farid of Schrödinger maintains that AI drug discovery won't work unless physics-based calculations are part of the ...

Discriminative AI, including machine learning and deep learning, is reshaping traditional industries while GenAI is starting ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Due to rising medication costs, many patients are forced to abandon their treatments. Additionally, the significant lack of ...

A report from market analysis firm Precedence Research reveals that the global AI drug discovery market size in 2024 is ...